A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
Clinical trial NCT06257875 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06257875
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-23
- Primary completion
- 2027-09-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.